If a Factor X assay shows an inhibitor, which interpretation is most likely?

If a Factor X assay shows an inhibitor, which interpretation is most likely?

• A. Factor Deficiency
• B. Clotted Sample
• C. Inhibitor
• D. Bad Draw

Answer: (C)

When a Factor X assay shows an inhibitor, the most likely interpretation is that an antibody or other inhibitory substance is actively neutralizing Factor X rather than there simply being less Factor X present. This points to an acquired Factor X inhibitor rather than a quantitative deficiency. Why this fits: a true deficiency means there isn’t enough Factor X, but mixing patient plasma with normal plasma would usually supply functional Factor X and correct the problem. An inhibitor, however, blocks Factor X activity regardless of the amount present, so the abnormal result tends not to correct with mixing. This is different from issues like a clotted sample or a bad draw, which cause technical artefacts rather than a specific inhibitory effect on Factor X activity. In practice, you’d use a mixing study to help distinguish between deficiency and inhibition: persistence of low Factor X activity after mixing supports an inhibitor. If an inhibitor is suspected, a quantitative inhibitor assay (such as a Bethesda-type approach) can help confirm and measure its strength.

When a Factor X assay shows an inhibitor, the most likely interpretation is that an antibody or other inhibitory substance is actively neutralizing Factor X rather than there simply being less Factor X present. This points to an acquired Factor X inhibitor rather than a quantitative deficiency.

Why this fits: a true deficiency means there isn’t enough Factor X, but mixing patient plasma with normal plasma would usually supply functional Factor X and correct the problem. An inhibitor, however, blocks Factor X activity regardless of the amount present, so the abnormal result tends not to correct with mixing. This is different from issues like a clotted sample or a bad draw, which cause technical artefacts rather than a specific inhibitory effect on Factor X activity.

In practice, you’d use a mixing study to help distinguish between deficiency and inhibition: persistence of low Factor X activity after mixing supports an inhibitor. If an inhibitor is suspected, a quantitative inhibitor assay (such as a Bethesda-type approach) can help confirm and measure its strength.